Synopsis: AbbVie’s blockbuster hopeful Rinvoq notched a win in a tricky-to-treat group of Crohn’s disease patients. The trial studied the AbbVie drug…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Clinical
-
-
AgrochemicalsBayer
Bayer’s Nubeqa Ameliorate Endurance in Prostate Cancer Clinical Trial
by adminby adminSummary – Bayer’s blockbuster hopes for Nubeqa just got a little brighter, thanks to a phase 3 trial win that could result…
-
Agrochemicals
The USFDA Grants Orphan Drug Designation to CT120 a Novel CAR T-Cell Therapy of IASO Biotherapeutics for Acute Lymphoblastic Leukemia
by adminby adminKEYPOINTS: The FDA has granted orphan drug designation (ODD) to CT120 for the treatment of acute lymphoblastic leukemia, a novel chimeric antigen…
-
Agrochemicals
New Proton Pump Inhibitors – Crystalline Patent Abeprazan Succinate (DWP14012) – Granted to Korean Firm Daewoong
by adminby adminAbeprazan (DWP14012) is a potassium-competitive acid blocker. Abeprazan inhibits H+, K+– ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan is…
-
Agrochemicals
BioMarin`s VOXZOGO (Vosoritide) becomes the First U.S.FDA-approved Drug Therapy for Dwarfism.
by adminby adminSynopsis: BioMarin Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to VOXZOGO™ (Vosoritide) for Injection, indicated…
-
Agrochemicals
Pfizer to allow Generic Versions of its Covid-19 Pill (Paxlovid) in 95 Countries
by adminby adminKEYPOINTS: Pfizer Inc allow generic manufacturers to supply its experimental antiviral Covid-19 pill to 95 low- and middle-income countries. This will be…
-
Agrochemicals
Omnicell and Fresenius Kabi Collaborate to Enhance Management of Controlled Substances in U.S. Hospitals
by adminby adminKEYPOINTS: Omnicell and Fresenius Kabi announced that they are collaborating on new technology for managing controlled substances. Automated Controlled Substance Dispenser to…
-
Iptacopan
Novartis Pharmaceuticals UK awarded an Innovation Passport for Investigational Oral Therapy Iptacopan (LNP023)
by adminby adminSUMMARY: Iptacopan has been awarded the Innovation Passport for the treatment of C3 glomerulopathy (C3G) and is currently being investigated in a…
-
CompaniesPfizer
BioNTech Deal With Senegal, Rwanda to Make mRNA Vaccine in Mid 2022
by adminby adminSummary- BioNTech in bid to build manufacturing expertise in Africa Project seeks to avoid repeat of COVID-19 vaccine inequality Backed by EU…
-
CompaniesMerck & Co
Merck’s Keytruda Gets EU Approval for Treatment of Triple-Negative Breast Cancer.
by adminby adminThe European Commission has cleared Keytruda (Pembrolizumab) in combination with chemotherapy as a first-line treatment for locally recurrent, unresectable or metastatic TNBC…